Floyd Christopher Holsinger
Research Subjects
Research Interests
Floyd Christopher Holsinger has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
Kitti Jantharapattana
Department of Otolaryngology – Head and Neck Surgery, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
4 shared publicationsOllivier Laccourreye
4 shared publicationsRandal S. Weber
4 shared publicationsCarol M. Lewis
3 shared publications- Jan S. Lewin
Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
3 shared publications - Robert L. Ferris
UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania
3 shared publications
Latest Publications
- 1 January 2015
- Published by Springer Nature
- p. 111-127
The Care of the HPV-Negative Head and Neck Cancer Patient: Presentation, Prognosis, Treatment
- 1 January 2015
- Published by Springer Nature
- p. 111-127
The Care of the HPV-Negative Head and Neck Cancer Patient: Presentation, Prognosis, Treatment
- 20 March 2013
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 31 (9) , e137-e140
Biomarker-Directed Therapy of Squamous Carcinomas of the Head and Neck: Targeting PI3K/PTEN/mTOR Pathway
- 20 March 2013
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 31 (9) , e137-e140
Biomarker-Directed Therapy of Squamous Carcinomas of the Head and Neck: Targeting PI3K/PTEN/mTOR Pathway
- 1 October 2012
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 121 (10) , 664-670
Functional and Oncological Outcomes of Primary versus Salvage Transoral Laser Microsurgery for Supraglottic Carcinoma
Objectives: We evaluated the functional and oncological outcomes of transoral laser microsurgery (TLM) in patients with previously untreated supraglottic carcinoma compared with the outcomes in salvage cases after radiation-based treatment. Methods: We conducted a retrospective case-control study at a single academic tertiary care institution. The functional outcomes were stratified by prior irradiation and were assessed at baseline, less than 1 week after operation, and at last follow-up. Results: Five patients underwent TLM for previously untreated disease, and 5 previously irradiated patients underwent salvage TLM for local failure. No patient required tracheostomy. There was no local recurrence after TLM as primary therapy, and none of those patients required radiotherapy. One salvage patient developed local recurrence. The duration of feeding tube dependence (p = 0.049) and the rates of chronic aspiration (more than 1 month after operation; p = 0.048) were significantly higher in the salvage TLM cases than in the previously untreated cases. The median scores on the PSS-HN Understandability of Speech were 75 (“usually understandable”) in the salvage group and 100 (“always understandable”) in the previously untreated group. Conclusions: Both local control and function were better in the previously untreated patients than in the salvage patients. Our findings provide support for the use of TLM as a primary treatment modality for selected supraglottic carcinomas, but also suggest a potential for functional recovery in both previously untreated and salvage cases.
- 1 October 2012
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 121 (10) , 664-670
Functional and Oncological Outcomes of Primary versus Salvage Transoral Laser Microsurgery for Supraglottic Carcinoma
Objectives: We evaluated the functional and oncological outcomes of transoral laser microsurgery (TLM) in patients with previously untreated supraglottic carcinoma compared with the outcomes in salvage cases after radiation-based treatment. Methods: We conducted a retrospective case-control study at a single academic tertiary care institution. The functional outcomes were stratified by prior irradiation and were assessed at baseline, less than 1 week after operation, and at last follow-up. Results: Five patients underwent TLM for previously untreated disease, and 5 previously irradiated patients underwent salvage TLM for local failure. No patient required tracheostomy. There was no local recurrence after TLM as primary therapy, and none of those patients required radiotherapy. One salvage patient developed local recurrence. The duration of feeding tube dependence (p = 0.049) and the rates of chronic aspiration (more than 1 month after operation; p = 0.048) were significantly higher in the salvage TLM cases than in the previously untreated cases. The median scores on the PSS-HN Understandability of Speech were 75 (“usually understandable”) in the salvage group and 100 (“always understandable”) in the previously untreated group. Conclusions: Both local control and function were better in the previously untreated patients than in the salvage patients. Our findings provide support for the use of TLM as a primary treatment modality for selected supraglottic carcinomas, but also suggest a potential for functional recovery in both previously untreated and salvage cases.
- 2 July 2012
- Published by Wiley in The Laryngoscope
- Vol. 122 (8) , 1701-1707
Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins
Objectives/Hypothesis: Our objective was to determine the safety, feasibility, and the adequacy of surgical margins for transoral robotic surgery (TORS), by reviewing the early results from independent institutional review board‐approved clinical trials in three separate institutions.Study Design: Pooled Data from Independent Prospective Clinical Trials.Methods: One hundred ninety‐two patients were initially screened, but inadequate exposure did not permit TORS in 13 (6.7%). For two additional patients, TORS was begun but intraoperatively converted to an open procedure. Thus, the intent‐to‐treat population was 177 patients (average age, 59 years; 81% male), predominantly comprised of tumors arising in the oropharynx (139, 78%) and larynx (26, 15%). TORS was performed for 161 (91%) patients with malignant disease: 153 (95%) with squamous cell carcinoma (T1 [50, 32.7%], T2 [74, 48.4%], T3 [21, 13.7%], T4 [8, 5.2%]), six patients (3.72%) with salivary gland tumors, and two patients with carcinoma in situ. The average follow‐up was 345 days.Results: There was no intraoperative mortality or death in the immediate postoperative period. Average estimated blood loss was 83 mL; no patient required transfusion. The rate of positive margins was 4.3%. Twenty‐nine patients (16%) experienced 34 serious adverse events that required hospitalization or intervention (grade 3) or were considered life threatening (grade 4, 2.3%). Tracheostomy was performed in 12.4% of all patients (22/177), but only 2.3% had a tracheostomy at last follow‐up. For all patients undergoing TORS without previous therapy, the percutaneous endoscopic gastrostomy dependency rate was 5.0%. The average hospital stay was 4.2 days.Conclusions: Based on this multicenter study, TORS appears to be safe, feasible, and as such play an important role in the multidisciplinary management of head and neck cancer.
- 2 July 2012
- Published by Wiley in The Laryngoscope
- Vol. 122 (8) , 1701-1707
Transoral robotic surgery: A multicenter study to assess feasibility, safety, and surgical margins
Objectives/Hypothesis: Our objective was to determine the safety, feasibility, and the adequacy of surgical margins for transoral robotic surgery (TORS), by reviewing the early results from independent institutional review board‐approved clinical trials in three separate institutions.Study Design: Pooled Data from Independent Prospective Clinical Trials.Methods: One hundred ninety‐two patients were initially screened, but inadequate exposure did not permit TORS in 13 (6.7%). For two additional patients, TORS was begun but intraoperatively converted to an open procedure. Thus, the intent‐to‐treat population was 177 patients (average age, 59 years; 81% male), predominantly comprised of tumors arising in the oropharynx (139, 78%) and larynx (26, 15%). TORS was performed for 161 (91%) patients with malignant disease: 153 (95%) with squamous cell carcinoma (T1 [50, 32.7%], T2 [74, 48.4%], T3 [21, 13.7%], T4 [8, 5.2%]), six patients (3.72%) with salivary gland tumors, and two patients with carcinoma in situ. The average follow‐up was 345 days.Results: There was no intraoperative mortality or death in the immediate postoperative period. Average estimated blood loss was 83 mL; no patient required transfusion. The rate of positive margins was 4.3%. Twenty‐nine patients (16%) experienced 34 serious adverse events that required hospitalization or intervention (grade 3) or were considered life threatening (grade 4, 2.3%). Tracheostomy was performed in 12.4% of all patients (22/177), but only 2.3% had a tracheostomy at last follow‐up. For all patients undergoing TORS without previous therapy, the percutaneous endoscopic gastrostomy dependency rate was 5.0%. The average hospital stay was 4.2 days.Conclusions: Based on this multicenter study, TORS appears to be safe, feasible, and as such play an important role in the multidisciplinary management of head and neck cancer.
- Open Access
Late dysphagia after radiotherapy‐based treatment of head and neck cancer
BACKGROUND: Changing trends in head and neck cancer (HNC) merit an understanding of the late effects of therapy, but few studies examine dysphagia beyond 2 years of treatment.METHODS: A case series was examined to describe the pathophysiology and outcomes in dysphagic HNC survivors referred for modified barium swallow (MBS) studies ≥5 years after definitive radiotherapy or chemoradiotherapy (January 2001 through May 2011). Functional measures included the penetration‐aspiration scale (PAS), performance status scale–head and neck (PSS‐HN), National Institutes of Health Swallowing Safety Scale (NIH‐SSS), and MBS impairment profile (MBSImp).RESULTS: Twenty‐nine patients previously treated with radiotherapy (38%) or chemoradiotherapy (62%) were included (median years posttreatment, 9; range, 5‐19). The majority (86%) had oropharyngeal cancer; 52% were never‐smokers. Seventy‐five percent had T2 or T3 tumors; 52% were N+. The median age at diagnosis was 55 (range, 38‐72). Abnormal late examination findings included: dysarthria/dysphonia (76%), cranial neuropathy (48%), trismus (38%), and radionecrosis (10%). MBS studies confirmed pharyngeal residue and aspiration in all dysphagic cases owing to physiologic impairment (median PAS, 8; median NIH‐SSS, 10; median MBSImp, 18), whereas stricture was confirmed endoscopically in 7 (24%). Twenty‐five (86%) developed pneumonia, half requiring hospitalization. Swallow postures/strategies helped 69% of cases, but no patient achieved durable improvement across functional measures at last follow‐up. Ultimately, 19 (66%) were gastrostomy‐dependent.CONCLUSIONS: Although functional organ preservation is commonly achieved, severe dysphagia represents a challenging late effect that may develop or progress years after radiation‐based therapy for HNC. These data suggest that novel approaches are needed to minimize and better address this complication that is commonly refractory to many standard dysphagia therapies. Cancer 2012. © 2012 American Cancer Society.
Open AccessLate dysphagia after radiotherapy‐based treatment of head and neck cancer
BACKGROUND: Changing trends in head and neck cancer (HNC) merit an understanding of the late effects of therapy, but few studies examine dysphagia beyond 2 years of treatment.METHODS: A case series was examined to describe the pathophysiology and outcomes in dysphagic HNC survivors referred for modified barium swallow (MBS) studies ≥5 years after definitive radiotherapy or chemoradiotherapy (January 2001 through May 2011). Functional measures included the penetration‐aspiration scale (PAS), performance status scale–head and neck (PSS‐HN), National Institutes of Health Swallowing Safety Scale (NIH‐SSS), and MBS impairment profile (MBSImp).RESULTS: Twenty‐nine patients previously treated with radiotherapy (38%) or chemoradiotherapy (62%) were included (median years posttreatment, 9; range, 5‐19). The majority (86%) had oropharyngeal cancer; 52% were never‐smokers. Seventy‐five percent had T2 or T3 tumors; 52% were N+. The median age at diagnosis was 55 (range, 38‐72). Abnormal late examination findings included: dysarthria/dysphonia (76%), cranial neuropathy (48%), trismus (38%), and radionecrosis (10%). MBS studies confirmed pharyngeal residue and aspiration in all dysphagic cases owing to physiologic impairment (median PAS, 8; median NIH‐SSS, 10; median MBSImp, 18), whereas stricture was confirmed endoscopically in 7 (24%). Twenty‐five (86%) developed pneumonia, half requiring hospitalization. Swallow postures/strategies helped 69% of cases, but no patient achieved durable improvement across functional measures at last follow‐up. Ultimately, 19 (66%) were gastrostomy‐dependent.CONCLUSIONS: Although functional organ preservation is commonly achieved, severe dysphagia represents a challenging late effect that may develop or progress years after radiation‐based therapy for HNC. These data suggest that novel approaches are needed to minimize and better address this complication that is commonly refractory to many standard dysphagia therapies. Cancer 2012. © 2012 American Cancer Society.
- 9 May 2011
- Published by Springer Nature
- p. 457-470
Cancers of the Larynx: Tis, T1, T2 Evaluation and Management
- 9 May 2011
- Published by Springer Nature
- p. 457-470
Cancers of the Larynx: Tis, T1, T2 Evaluation and Management
- 26 April 2011
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 5 (3) , 221-226
Retropharyngeal lymphadenectomy with transoral robotic surgery for papillary thyroid cancer
Retropharyngeal metastasis of papillary thyroid carcinoma is a rare but well recognized phenomenon. Traditional open surgical approaches to nodal metastasis located in the retropharyngeal space are particularly morbid considering the relatively indolent nature of some thyroid cancers. Minimally invasive surgical approaches offer a useful alternative that is both low in morbidity and high in levels of patient acceptance. To assess feasibility and safety, we report a case series of robotic lymphadenectomy in two patients with thyroid cancer metastatic to the retropharyngeal space. Two patients, ages 66 and 73, with unilateral recurrent papillary carcinoma of the retropharyngeal lymph nodes had previously undergone thyroidectomy, neck dissection, and radioactive iodine ablation prior to retropharyngeal resection. Retropharyngeal lymphadenectomy via transoral robotic surgery was performed for both patients: for the first, the oropharyngeal wound was left to heal by secondary intention, while for the other patient, simple pharyngeal flap closure was performed. Retropharyngeal lymph node dissections were successfully carried out using a transoral robotic retropharyngotomy with the da Vinci surgical robotic system. Both patients tolerated the procedure well. One patient did developed temporary dysphagia which resolved with conservative measures, not requiring a feeding tube. We report the first two cases of transoral robot-assisted resection of thyroid cancer metastatic to the retropharyngeal lymph nodes. The technique is feasible, minimally invasive, and appears to be as safe as conventional surgical methods in achieving the goals of management of regionally metastatic disease.
- 26 April 2011
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 5 (3) , 221-226
Retropharyngeal lymphadenectomy with transoral robotic surgery for papillary thyroid cancer
Retropharyngeal metastasis of papillary thyroid carcinoma is a rare but well recognized phenomenon. Traditional open surgical approaches to nodal metastasis located in the retropharyngeal space are particularly morbid considering the relatively indolent nature of some thyroid cancers. Minimally invasive surgical approaches offer a useful alternative that is both low in morbidity and high in levels of patient acceptance. To assess feasibility and safety, we report a case series of robotic lymphadenectomy in two patients with thyroid cancer metastatic to the retropharyngeal space. Two patients, ages 66 and 73, with unilateral recurrent papillary carcinoma of the retropharyngeal lymph nodes had previously undergone thyroidectomy, neck dissection, and radioactive iodine ablation prior to retropharyngeal resection. Retropharyngeal lymphadenectomy via transoral robotic surgery was performed for both patients: for the first, the oropharyngeal wound was left to heal by secondary intention, while for the other patient, simple pharyngeal flap closure was performed. Retropharyngeal lymph node dissections were successfully carried out using a transoral robotic retropharyngotomy with the da Vinci surgical robotic system. Both patients tolerated the procedure well. One patient did developed temporary dysphagia which resolved with conservative measures, not requiring a feeding tube. We report the first two cases of transoral robot-assisted resection of thyroid cancer metastatic to the retropharyngeal lymph nodes. The technique is feasible, minimally invasive, and appears to be as safe as conventional surgical methods in achieving the goals of management of regionally metastatic disease.
- 1 January 2011
- Published by Elsevier
- p. 397-408
Transoral Laser Resection of Glottic Tumors
- 1 January 2011
- Published by Elsevier
- p. 298-305
Transoral Robotic Surgery
- 1 January 2011
- Published by Elsevier
- p. 383-388
Tracheoesophageal Puncture in the Clinic via Transnasal Esophagoscopy
- 1 January 2011
- Published by Elsevier
- p. 383-388
Tracheoesophageal Puncture in the Clinic via Transnasal Esophagoscopy